138 related articles for article (PubMed ID: 18467632)
21. The origin of post-injury neointimal cells in the rat balloon injury model.
Rodriguez-Menocal L; St-Pierre M; Wei Y; Khan S; Mateu D; Calfa M; Rahnemai-Azar AA; Striker G; Pham SM; Vazquez-Padron RI
Cardiovasc Res; 2009 Jan; 81(1):46-53. PubMed ID: 18818213
[TBL] [Abstract][Full Text] [Related]
22. Vascular endothelial cell-derived endothelin-1 mediates vascular inflammation and neointima formation following blood flow cessation.
Anggrahini DW; Emoto N; Nakayama K; Widyantoro B; Adiarto S; Iwasa N; Nonaka H; Rikitake Y; Kisanuki YY; Yanagisawa M; Hirata K
Cardiovasc Res; 2009 Apr; 82(1):143-51. PubMed ID: 19164391
[TBL] [Abstract][Full Text] [Related]
23. Smooth muscle-targeted knockout of connexin43 enhances neointimal formation in response to vascular injury.
Liao Y; Regan CP; Manabe I; Owens GK; Day KH; Damon DN; Duling BR
Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1037-42. PubMed ID: 17332489
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of endothelin ETB receptor system aggravates neointimal hyperplasia after balloon injury of rat carotid artery.
Kitada K; Yui N; Matsumoto C; Mori T; Ohkita M; Matsumura Y
J Pharmacol Exp Ther; 2009 Dec; 331(3):998-1004. PubMed ID: 19737855
[TBL] [Abstract][Full Text] [Related]
25. Angiotensin II type 1 receptor-associated protein regulates carotid intimal hyperplasia through controlling apoptosis of vascular smooth muscle cells.
Yue Y; Ma K; Li Z; Wang Z
Biochem Biophys Res Commun; 2018 Jan; 495(2):2030-2037. PubMed ID: 29247644
[TBL] [Abstract][Full Text] [Related]
26. Fludarabine prevents smooth muscle proliferation in vitro and neointimal hyperplasia in vivo through specific inhibition of STAT-1 activation.
Torella D; Curcio A; Gasparri C; Galuppo V; De Serio D; Surace FC; Cavaliere AL; Leone A; Coppola C; Ellison GM; Indolfi C
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2935-43. PubMed ID: 17293493
[TBL] [Abstract][Full Text] [Related]
27. Drug-eluting stents: sirolimus and paclitaxel differentially affect cultured cells and injured arteries.
Parry TJ; Brosius R; Thyagarajan R; Carter D; Argentieri D; Falotico R; Siekierka J
Eur J Pharmacol; 2005 Nov; 524(1-3):19-29. PubMed ID: 16271360
[TBL] [Abstract][Full Text] [Related]
28. Late outgrowth endothelial cells derived from Wharton jelly in human umbilical cord reduce neointimal formation after vascular injury: involvement of pigment epithelium-derived factor.
Wang SH; Lin SJ; Chen YH; Lin FY; Shih JC; Wu CC; Wu HL; Chen YL
Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):816-22. PubMed ID: 19342598
[TBL] [Abstract][Full Text] [Related]
29. Smooth muscle calponin: an unconventional CArG-dependent gene that antagonizes neointimal formation.
Long X; Slivano OJ; Cowan SL; Georger MA; Lee TH; Miano JM
Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2172-80. PubMed ID: 21817093
[TBL] [Abstract][Full Text] [Related]
30. Endothelial Myocyte Enhancer Factor 2c Inhibits Migration of Smooth Muscle Cells Through Fenestrations in the Internal Elastic Lamina.
Lu YW; Lowery AM; Sun LY; Singer HA; Dai G; Adam AP; Vincent PA; Schwarz JJ
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1380-1390. PubMed ID: 28473437
[TBL] [Abstract][Full Text] [Related]
31. A secreted soluble form of LR11, specifically expressed in intimal smooth muscle cells, accelerates formation of lipid-laden macrophages.
Ohwaki K; Bujo H; Jiang M; Yamazaki H; Schneider WJ; Saito Y
Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1050-6. PubMed ID: 17332490
[TBL] [Abstract][Full Text] [Related]
32. The bone morphogenetic protein antagonist gremlin promotes vascular smooth muscle cell apoptosis.
Maciel TT; Melo RS; Campos AH
J Vasc Res; 2009; 46(4):325-32. PubMed ID: 19142012
[TBL] [Abstract][Full Text] [Related]
33. Activation transcription factor-4 induced by fibroblast growth factor-2 regulates vascular endothelial growth factor-A transcription in vascular smooth muscle cells and mediates intimal thickening in rat arteries following balloon injury.
Malabanan KP; Kanellakis P; Bobik A; Khachigian LM
Circ Res; 2008 Aug; 103(4):378-87. PubMed ID: 18617696
[TBL] [Abstract][Full Text] [Related]
34. alpha8beta1 Integrin is up-regulated in the neointima concomitant with late luminal loss after balloon injury.
Zargham R; Pepin J; Thibault G
Cardiovasc Pathol; 2007; 16(4):212-20. PubMed ID: 17637429
[TBL] [Abstract][Full Text] [Related]
35. Wilms' tumor 1-associating protein regulates the proliferation of vascular smooth muscle cells.
Small TW; Bolender Z; Bueno C; O'Neil C; Nong Z; Rushlow W; Rajakumar N; Kandel C; Strong J; Madrenas J; Pickering JG
Circ Res; 2006 Dec; 99(12):1338-46. PubMed ID: 17095724
[TBL] [Abstract][Full Text] [Related]
36. Smooth muscle LDL receptor-related protein-1 inactivation reduces vascular reactivity and promotes injury-induced neointima formation.
Basford JE; Moore ZW; Zhou L; Herz J; Hui DY
Arterioscler Thromb Vasc Biol; 2009 Nov; 29(11):1772-8. PubMed ID: 19729608
[TBL] [Abstract][Full Text] [Related]
37. Phytoestrogen derivatives differentially inhibit arterial neointimal proliferation in a mouse model.
Shen J; White M; Husband AJ; Hambly BD; Bao S
Eur J Pharmacol; 2006 Oct; 548(1-3):123-8. PubMed ID: 16950243
[TBL] [Abstract][Full Text] [Related]
38. Dextromethorphan reduces oxidative stress and inhibits atherosclerosis and neointima formation in mice.
Liu SL; Li YH; Shi GY; Tang SH; Jiang SJ; Huang CW; Liu PY; Hong JS; Wu HL
Cardiovasc Res; 2009 Apr; 82(1):161-9. PubMed ID: 19189960
[TBL] [Abstract][Full Text] [Related]
39. Vitronectin is up-regulated after vascular injury and vitronectin blockade prevents neointima formation.
Dufourcq P; Couffinhal T; Alzieu P; Daret D; Moreau C; Duplàa C; Bonnet J
Cardiovasc Res; 2002 Mar; 53(4):952-62. PubMed ID: 11922905
[TBL] [Abstract][Full Text] [Related]
40. Cell-specific effects of miR-221/222 in vessels: molecular mechanism and therapeutic application.
Liu X; Cheng Y; Yang J; Xu L; Zhang C
J Mol Cell Cardiol; 2012 Jan; 52(1):245-55. PubMed ID: 22138289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
